53819-93-5 ((N-methylglycyl-N~5~-(diaminomethylidene)-L-ornithyl-L-valyl-L-tyrosyl-L-valyl-L-histidyl-(4R)-4-hydroxy-L-prolyl-N-methyl-L-phenylalanine)

N-methylglycyl-N~5~-(diaminomethylidene)-L-ornithyl-L-valyl-L-tyrosyl-L-valyl-L-histidyl-(4R)-4-hydroxy-L-prolyl-N-methyl-L-phenylalanine;Shpmp-angiotensin II;53819-93-5;Angiotensin II, sarcosyl(1)-hydroxyprolyl(7)-N-methylphenylalanine(8)-;Angiotensin II, 1-(N-methylglycine)-5-L-valine-7-(trans-4-hydroxy-L-proline)-8-(N-methyl-L-phenylalanine)-;Angiotensin II, sar(1)-hydroxy-pro(7)-N-Me-phe(8)-;1-Sarcosyl-7-hydroxyprolyl-8-N-methylphenylalanine-angiotensin II;1-Sar-7-hydroxy-pro-8-N-methyl-phe-angiotensin II;

NDGCQRDOIWRPFJ-FNVUWGPDSA-N

1S/C49H71N13O11/c1-27(2)40(59-42(66)34(56-39(65)24-52-5)13-10-18-54-49(50)51)44(68)57-35(19-30-14-16-32(63)17-15-30)43(67)60-41(28(3)4)45(69)58-36(21-31-23-53-26-55-31)46(70)62-25-33(64)22-37(62)47(71)61(6)38(48(72)73)20-29-11-8-7-9-12-29/h7-9,11-12,14-17,23,26-28,33-38,40-41,52,63-64H,10,13,18-22,24-25H2,1-6H3,(H,53,55)(H,56,65)(H,57,68)(H,58,69)(H,59,66)(H,60,67)(H,72,73)(H4,50,51,54)/t33-,34+,35+,36+,37+,38+,40+,41+/m1/s1

O[C@H]1CN(C([C@H](CC2=CN=CN2)NC([C@H](C(C)C)NC([C@H](CC2C=CC(=CC=2)O)NC([C@H](C(C)C)NC([C@H](CCC/N=C(\N)/N)NC(CNC)=O)=O)=O)=O)=O)=O)[C@H](C(N(C)[C@H](C(=O)O)CC2C=CC=CC=2)=O)C1